Nikoletta Psatha

1.1k total citations
32 papers, 661 citations indexed

About

Nikoletta Psatha is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Nikoletta Psatha has authored 32 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Genetics and 11 papers in Genetics. Recurrent topics in Nikoletta Psatha's work include Virus-based gene therapy research (17 papers), CRISPR and Genetic Engineering (15 papers) and Hemoglobinopathies and Related Disorders (9 papers). Nikoletta Psatha is often cited by papers focused on Virus-based gene therapy research (17 papers), CRISPR and Genetic Engineering (15 papers) and Hemoglobinopathies and Related Disorders (9 papers). Nikoletta Psatha collaborates with scholars based in United States, Greece and Germany. Nikoletta Psatha's co-authors include Evangelia Yannaki, Thalia Papayannopoulou, André Lieber, Chang Li, Hongjie Wang, Sucheol Gil, George Stamatoyannopoulos, Αchilles Anagnostopoulos, Zsuzsanna Izsvák and Anja Ehrhardt and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Nikoletta Psatha

30 papers receiving 657 citations

Peers

Countries citing papers authored by Nikoletta Psatha

Since Specialization

Citations

This map shows the geographic impact of Nikoletta Psatha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikoletta Psatha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikoletta Psatha more than expected).

Fields of papers citing papers by Nikoletta Psatha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikoletta Psatha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikoletta Psatha. The network helps show where Nikoletta Psatha may publish in the future.

Co-authorship network of co-authors of Nikoletta Psatha

This figure shows the co-authorship network connecting the top 25 collaborators of Nikoletta Psatha. A scholar is included among the top collaborators of Nikoletta Psatha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikoletta Psatha. Nikoletta Psatha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Large-scale discovery of potent, compact and erythroid specific enhancers for gene therapy vectors 2025 ·Nature Communications ·Nikoletta Psatha, Pavel Sova, Grigorios Georgolopoulos, (unknown), Mineo Iwata, (unknown), (unknown), Hao Wang, (unknown), (unknown), Matthew S. Wilken, J Stamatoyannopoulos, Evangelia Yannaki, (unknown), George Stamatoyannopoulos, Jeff Vierstra	0
2	Single-cell spatial multi-omics and deep learning dissect enhancer-driven gene regulatory networks in liver zonation 2024 ·Nature Cell Biology ·Carmen Bravo González‐Blas, Irina Matetovici, Hanne Hillen, Ibrahim Ihsan Taskiran, Roel Vandepoel, Valerie Christiaens, Leticia Sansores-García, Elisabeth Verboven, Gert Hulselmans, Suresh Poovathingal, Jonas Demeulemeester, Nikoletta Psatha, David Mauduit, Georg Halder, Stein Aerts	30
3	Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies 2023 ·International Journal of Molecular Sciences ·(unknown), Evangelia Yannaki, Nikoletta Psatha	13
4	Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy 2023 ·Cancers ·(unknown), (unknown), Nikoletta Psatha, Ioanna Sakellari, Evangelia Yannaki, Αναστασία Παπαδοπούλου	7
5	Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming 2023 ·Cancers ·Maria V. Alvanou, (unknown), (unknown), Nikoletta Psatha, Alexandros Spyridonidis, Αναστασία Παπαδοπούλου, Evangelia Yannaki	16
6	Success Stories and Challenges Ahead in Hematopoietic Stem Cell Gene Therapy: Hemoglobinopathies as Disease Models 2021 ·Human Gene Therapy ·Evangelia Yannaki, Nikoletta Psatha, Αναστασία Παπαδοπούλου, Takis Athanasopoulos, (unknown), Maria G. Roubelakis, Panagiotis Tsirigotis, Αchilles Anagnostopoulos, Nicholas P. Anagnou, George Vassilopoulos	5
7	Discrete regulatory modules instruct hematopoietic lineage commitment and differentiation 2021 ·Nature Communications ·Grigorios Georgolopoulos, Nikoletta Psatha, Mineo Iwata, Andrew Nishida, (unknown), Minas Yiangou, J Stamatoyannopoulos, Jeff Vierstra	10
8	Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo 2021 ·Blood ·Nikoletta Psatha, Aphrodite Georgakopoulou, Chang Li, Vivek Nandakumar, Grigorios Georgolopoulos, Reyes Acosta, (unknown), Jemma Nelson, Daniel R. Chee, Anastasia Athanasiadou, Anastasia Kouvatsi, Alister P. W. Funnell, André Lieber, Evangelia Yannaki, Thalia Papayannopoulou	29
9	Investigating the Barrier Activity of Novel, Human Enhancer-Blocking Chromatin Insulators for Hematopoietic Stem Cell Gene Therapy 2021 ·Human Gene Therapy ·(unknown), Nikoletta Psatha, (unknown), Li X, (unknown), Monica Volpin, Eugenio Montini, Mingdong Liu, (unknown), Minas Yiangou, David W. Emery, Αchilles Anagnostopoulos, Thalia Papayannopoulou, Suming Huang, George Stamatoyannopoulos, Evangelia Yannaki	4
10	“Cerberus” T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients 2021 ·Frontiers in Immunology ·(unknown), (unknown), Aphrodite Georgakopoulou, Maria V. Alvanou, (unknown), (unknown), (unknown), (unknown), Timoleon‐Achilleas Vyzantiadis, Alexandros Spyridonidis, Antonios M. Makris, Anastasia Chatzidimitriou, Nikoletta Psatha, Αchilles Anagnostopoulos, Evangelia Yannaki, Αναστασία Παπαδοπούλου	7
11	In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia 2018 ·Journal of Clinical Investigation ·Hongjie Wang, Aphrodite Georgakopoulou, Nikoletta Psatha, Chang Li, (unknown), (unknown), Αchilles Anagnostopoulos, Anja Ehrhardt, Zsuzsanna Izsvák, Thalia Papayannopoulou, Evangelia Yannaki, André Lieber	53
12	Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies 2018 ·Molecular Therapy — Methods & Clinical Development ·Chang Li, Nikoletta Psatha, Hongjie Wang, Manvendra Singh, (unknown), Wenli Zhang, Anja Ehrhardt, Zsuzsanna Izsvák, Thalia Papayannopoulou, André Lieber	28
13	Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major 2018 ·Molecular Therapy — Methods & Clinical Development ·Nikoletta Psatha, Andreas Reik, (unknown), Yuanyue Zhou, (unknown), Evangelia Yannaki, Dana N. Levasseur, Fyodor D. Urnov, Michael C. Holmes, Thalia Papayannopoulou	83
14	Genetics of the peloponnesean populations and the theory of extinction of the medieval peloponnesean Greeks 2017 ·European Journal of Human Genetics ·George Stamatoyannopoulos, (unknown), Athanasios Teodosiadis, Fotis Tsetsos, Anna Plantinga, Nikoletta Psatha, (unknown), Evangelia Yannaki, Pierre Zalloua, Kenneth K. Kídd, Brian L. Browning, J Stamatoyannopoulos, Peristera Paschou, Petros Drineas	11
15	In Vivo HSC Transduction and Selection Results in Long-Term, High-Level Expression of Human Gamma Globin in Peripheral Blood Erythrocytes of Mice 2017 ·Blood ·André Lieber, Hongjie Wang, Nikoletta Psatha, (unknown), Kevin G. Haworth, Anja Ehrhardt, Zsuzsanna Izsvák, Hans‐Peter Kiem, George Stamatoyannopoulos, Thalia Papayannopoulou	1
16	A Combined In Vivo HSC Transduction/Selection Approach Results in Efficient and Stable Gene Expression in Peripheral Blood Cells in Mice 2017 ·Molecular Therapy — Methods & Clinical Development ·Hongjie Wang, Maximilian Richter, Nikoletta Psatha, (unknown), Jiho Kim, Jing Liu, Anja Ehrhardt, Susan K. Nilsson, Benjamin Cao, Donna Palmer, Philip Ng, Zsuzsanna Izsvák, Kevin G. Haworth, Hans‐Peter Kiem, Thalia Papayannopoulou, André Lieber	39
17	Optimizing autologous cell grafts to improve stem cell gene therapy 2016 ·Experimental Hematology ·Nikoletta Psatha, (unknown), Evangelia Yannaki	19
18	Clinical-Scale Genome Editing of the Human BCL11A Erythroid Enhancer for Treatment of the Hemoglobinopathies 2015 ·Blood ·Fyodor D. Urnov, Andreas Reik, Jeff Vierstra, Kai-Hsin Chang, Yuanyue Zhou, (unknown), (unknown), (unknown), Nikoletta Psatha, Siyuan Tan, Evangelia Yannaki, Stewart Craig, Edward J. Rebar, J Stamatoyannopoulos, Thalia Papayannopoulou, George Stamatoyannopoulos, Haiyan Jiang	9
19	Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbb ^th-3 Mouse Model 2014 ·Human Gene Therapy Methods ·Nikoletta Psatha, (unknown), (unknown), (unknown), (unknown), Varnavas Constantinou, Evangelia Athanasiou, Minas Arsenakis, Αchilles Anagnostopoulos, Thalia Papayannopoulou, George Stamatoyannopoulos, Evangelia Yannaki	16
20	Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects 2011 ·Molecular Therapy ·Evangelia Yannaki, Thalia Papayannopoulou, Erica C. Jonlin, (unknown), (unknown), Angeliki Xagorari, Pamela S. Becker, Nikoletta Psatha, Ioannis Batsis, Panayotis Kaloyannidis, (unknown), Varnavas Constantinou, (unknown), Konstantia Kotta, Aglaia Athanassiadou, Αchilles Anagnostopoulos, Αthanasios Fassas, George Stamatoyannopoulos	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact